Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
16.96
+0.31 (1.86%)
Jul 8, 2025, 10:49 AM - Market open

Amarin Corporation Market Cap

Amarin Corporation has a market cap or net worth of $351.19 million as of July 8, 2025. Its market cap has increased by 17.06% in one year.

Market Cap
351.19M
Enterprise Value
73.32M
1-Year Change
17.06%
Ranking
Category
Stock Price
$16.96

Market Cap Chart

Since December 1, 1998, Amarin Corporation's market cap has decreased from $21.74B to $351.19M, a decrease of -98.38%. That is a compound annual growth rate of -14.36%.

History

DateMarket Cap% Change
Jul 7, 2025344.80M72.83%
Dec 31, 2024199.50M-43.83%
Dec 29, 2023355.20M-27.30%
Dec 30, 2022488.60M-63.37%
Dec 31, 20211.33B-29.85%
Dec 31, 20201.90B-75.29%
Dec 31, 20197.70B83.89%
Dec 31, 20184.18B285.24%
Dec 29, 20171.09B31.56%
Dec 30, 2016825.60M138.20%
Dec 31, 2015346.60M102.57%
Dec 31, 2014171.10M-49.69%
Dec 31, 2013340.10M-72.00%
Dec 31, 20121.21B19.39%
Dec 30, 20111.02B26.09%
Dec 31, 2010806.80M1,984.75%
Dec 31, 200938.70M-99.59%
Dec 29, 20069.44B90.00%
Dec 30, 20054.97B-55.72%
Dec 31, 200411.22B75.97%
Dec 31, 20036.38B-61.40%
Dec 31, 200216.53B-77.03%
Dec 31, 200171.94B215.82%
Dec 29, 200022.78B15.79%
Dec 31, 199919.67B33.43%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 693.83B
Johnson & Johnson 373.59B
AbbVie 331.43B
Novo Nordisk 308.12B
UnitedHealth Group 275.51B
Novartis AG 240.05B
Abbott Laboratories 232.62B
AstraZeneca 216.19B
Market Cap Rankings